Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950170-25-083240
Filing Date
2025-06-06
Accepted
2025-06-06 17:00:40
Documents
1
Period of Report
2025-06-05

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4105
  Complete submission text file 0000950170-25-083240.txt   5583
Mailing Address C/O CG ONCOLOGY, INC. 400 SPECTRUM DRIVE SUITE 2040 IRVINE CA 92618
Business Address
POST LEONARD E (Reporting) CIK: 0001235862 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-41925 | Film No.: 251031884

Mailing Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618
Business Address 400 SPECTRUM CENTER DRIVE SUITE 2040 IRVINE CA 92618 (949) 419-6203
CG Oncology, Inc. (Issuer) CIK: 0001991792 (see all company filings)

EIN.: 371611499 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)